As the world braces for new kinds of virus strains following the spread of the highly infectious Delta variant, the UAE gets into action by preparing to adopt a new technology that is reported to detect COVID-19 infections by 100%.
The said technology, known as CRISPR, was first introduced by French researcher Emmanuelle Charpentier and American researcher Jennifer A. Doudna as an emerging technology for detecting RNA as well as DNA in diagnosis in general, according to Sheikh Sultan Bin Saud Abdulaziz Al Mualla, CEO of Cooper Diagnostics, a UAE-based enterprise.
Soon, UAE to Adopt Tech that 100% Detects COVID-19
According to the report by Gulf Today, the two scientists were awarded the Nobel Prize in Chemistry in DNA technology last year, followed by the subsequent diagnosis of COVID-19.
Earlier, CRISPR has been granted an emergency use license from the US Food and Drug Administration (FDA) for the 100% accuracy and sensitivity in detecting the coronavirus during the first stage of infection.
More than the accuracy of diagnosis of the health crisis and enhancing the level of health care and treatment of the infected, the technology has also been granted an emergency license for use from the UAE Ministry of Health and Prevention (MOHAP).
By far, the tests conducted using this technology, according to Al Mualla, yielded 99.4% accuracy in detecting the Delta variant, which was first discovered in India.